Researchers at University of Alabama at Birmingham (UAB) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance. In findings published today online in two papers in the journal Nature, the research team describe the differences in an enzyme called RNA polymerase in bacterial cells as opposed to human cells. These differences provide potential new targets for drug design.
RNA polymerase is the key enzyme regulating the transfer of genetic information from DNA to RNA, said Dmitry Vassylyev, PhD, professor of biochemistry and molecular genetics and lead author of both papers. All living organisms use this enzyme to transmit the instructions stored in genes (DNA) to messenger RNA (mRNA), which in turn communicates those instructions to the cells.
Specifically, Vassylyevs team traced the similarities and differences between human RNA polymerase and bacteria RNA polymerase, painting a more complete picture of the structure of this essential enzyme.
Knowing how RNA polymerase differs in human and bacterial cells means antibiotics can be designed with a greater probability that they will interact with and kill bacteria, while leaving healthy human cells alone, Vassylyev said.
Vassylyev said that not only does this present a pathway for new antibiotics, it also should allow for existing drugs to be improved. Some antibiotics are very good at killing bacteria, for instance, but have a difficult time penetrating the cell membrane, rendering them fairly ineffective.
Vassylyevs detailed view of RNA polymerase provides a foundation for producing drugs that will efficiently enter cells, bind to the RNA polymerase and destroy bacteria without inhibiting the growth of human cells.
Vassylyev collaborated with Irina Artsimovitch of Ohio State University and Robert Laudick of the University of Wisconsin. The research was funded by the National Institute of General Medicine Sciences, one of the National Institutes of Health.
Source: UAB
Â
Â
Â
Â
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.